Denver Myeloma Roundtable image

Denver Myeloma Roundtable

Sep 12, 2026
08:00AM - 02:30PM MDT In the city timezone
Sheraton Denver Downtown Hotel
1550 Court Pl, Denver, CO 80202, USA
$ 25
Overview

Our Denver Myeloma Roundtable, held on September 12th, brought together leading myeloma experts, patients, and caregivers to explore the latest advances in myeloma treatment and research. The event featured patient-friendly presentations, interactive breakout sessions, and a faculty Q&A where attendees had the opportunity to ask questions directly to the experts.

Explore the presentations and discussions below to revisit key insights from the event.

Location: Sheraton Denver Downtown Hotel

User uploaded media
Highlights
Speakers & Moderators
Healthtree contact Jenny Ahlstrom

Jenny Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.
Healthtree contact Tara K. Gregory, MD

Tara K. Gregory, MD

Tara Gregory, MD, is a medical oncologist at the Colorado Blood Cancer Institute and Co-Director of the Plasma Cell Dyscrasia Program. She specializes in the treatment of multiple myeloma, amyloidosis, and other plasma cell disorders, with expertise in stem cell transplantation and cellular therapies. Dr. Gregory is actively involved in clinical research and has dedicated her career to advancing treatment options and improving outcomes for patients with blood cancers.
Healthtree contact Jorge Monge, MD

Jorge Monge, MD

Jorge Monge, MD, is a hematologist and medical oncologist at the University of Colorado specializing in multiple myeloma and other plasma cell disorders. He is actively involved in clinical research focused on advancing innovative therapies and improving outcomes for patients with blood cancers. Dr. Monge is committed to providing personalized, patient-centered care while helping bring the latest treatment advances to the myeloma community.
Healthtree contact Peter A. Forsberg, MD

Peter A. Forsberg, MD

Peter A. Forsberg, MD, is a hematologist and medical oncologist at the Colorado Blood Cancer Institute specializing in multiple myeloma and other plasma cell disorders. He serves as Director of Translational Research and is actively involved in clinical trials focused on developing new treatment options for patients with blood cancers. Dr. Forsberg is dedicated to advancing innovative therapies while providing compassionate, patient-centered care.
Healthtree contact Jeffrey V Matous, MD

Jeffrey V Matous, MD

Jeffrey V. Matous, MD, is a hematologist and medical oncologist at the Colorado Blood Cancer Institute with a special focus on multiple myeloma and other plasma cell disorders. He has been a leader in clinical research for more than two decades, helping bring innovative therapies and clinical trials to patients with blood cancers. Dr. Matous is dedicated to advancing myeloma care while providing personalized, patient-centered treatment.
Healthtree contact Kate Mimken, RN, BSN, FNP-C

Kate Mimken, RN, BSN, FNP-C

Kate Mimken, RN, BSN, MSN, FNP-C, is a nurse practitioner at the Colorado Blood Cancer Institute with extensive experience caring for patients with blood cancers. Throughout her oncology career, she has focused on helping patients navigate treatment, manage side effects, and maintain quality of life. Kate is passionate about patient education and empowering individuals and families with practical information to support their care journey.